AADPA is proud to present the first comprehensive ADHD Prescribing Guide for Australian Healthcare Professionals.
Developed collaboratively by a multidisciplinary group of clinicians, pharmacists, academics, and people with lived experience of ADHD, this guide provides end-to-end coverage of pharmacological management—from assessment and diagnosis through to treatment considerations for specific populations.
Given the significant variability in ADHD prescribing practices across Australia, this resource responds to a clear need for consistent, practical, and evidence-based guidance. It supports informed decision-making across age groups and clinical settings, helps address common prescribing questions, and aims to promote high-quality, consistent care for individuals with ADHD.
The guide is intended to support, not replace, clinical judgment. Recommendations are grounded in current evidence while recognising the importance of individualised care and clinician expertise. It will be regularly reviewed and updated to reflect emerging evidence and evolving best practice. Clinicians should always practise in accordance with regulatory requirements within their jurisdiction.
While the focus of this guide is pharmacological treatment, it acknowledges the essential role of comprehensive, multimodal care. Psychoeducation, psychological therapies, ADHD coaching, and other non-pharmacological interventions remain critical components of effective treatment plans. Supporting information sheets on psychoeducation and non-pharmacological approaches are available for free download.



